Evidence map›Paper›PMID 32086499›Full record

ReviewNature reviews. Gastroenterology & hepatology2020

Early-onset colorectal cancer: initial clues and current views.

Lorne J Hofseth, James R Hebert, Anindya Chanda, Hexin Chen, Bryan L Love, Maria M Pena, E Angela Murphy, Mathew Sajish, Amit Sheth, Phillip J Buckhaults and 1 more

Erratum issuedAbstract readReview
In one paragraph

Review in Nature reviews. Gastroenterology & hepatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 266 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
266citing papers in PubMed, 8 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

266 citing papers in PubMed, 8 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Review
  10. Review
  11. Review
  12. Tumor Exposomics: A New Paradigm for Individualized Continuous Exposure Monitoring.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

206 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Lorne J HofsethCenter for Colon Cancer Research, University of South Carolina, Columbia, SC, USA. hofseth@cop.sc.edu.
James R HebertCenter for Colon Cancer Research, University of South Carolina, Columbia, SC, USA.ORCID http://orcid.org/0000-0002-0677-2672
Anindya ChandaCenter for Colon Cancer Research, University of South Carolina, Columbia, SC, USA.
Hexin ChenCenter for Colon Cancer Research, University of South Carolina, Columbia, SC, USA.ORCID http://orcid.org/0000-0001-9300-0859
Bryan L LoveCenter for Colon Cancer Research, University of South Carolina, Columbia, SC, USA.
Maria M PenaCenter for Colon Cancer Research, University of South Carolina, Columbia, SC, USA.
E Angela MurphyCenter for Colon Cancer Research, University of South Carolina, Columbia, SC, USA.
Mathew SajishCenter for Colon Cancer Research, University of South Carolina, Columbia, SC, USA.
Amit ShethCenter for Colon Cancer Research, University of South Carolina, Columbia, SC, USA.
Phillip J BuckhaultsCenter for Colon Cancer Research, University of South Carolina, Columbia, SC, USA.
Franklin G BergerCenter for Colon Cancer Research, University of South Carolina, Columbia, SC, USA.

Funding

A Transdisciplinary Approach to Investigating Metabolic Dysregulation in Obese Parent and Child Dyads and Risk of Colorectal Cancer - admin supplementU01CA272977 · NCI · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI JAMES R HEBERT, Lorne J Hofseth · 2022 to 2026
$4.7M
Harnessing the Power of p53 with Panaxynol from American Ginseng to Suppress Colitis and Prevent Colon Cancer - admin suppR01CA246809 · NCI · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI HOFSETH, LORNE J, MURPHY, ELIZABETH ANGELA · 2020 to 2024
$2.2M
NCI NIH HHS R01 CA246809NCI NIH HHS U01 CA272977
6 · The paper itself

Abstract

Over the past several decades, the incidence of early-onset colorectal cancer (EOCRC; in patients <50 years old) has increased at an alarming rate. Although robust and scientifically rigorous epidemiological studies have sifted out environmental elements linked to EOCRC, our knowledge of the causes and mechanisms of this disease is far from complete. Here, we highlight potential risk factors and putative mechanisms that drive EOCRC and suggest likely areas for fruitful research. In addition, we identify inconsistencies in the evidence implicating a strong effect of increased adiposity and suggest that certain behaviours (such as diet and stress) might place nonobese and otherwise healthy people at risk of this disease. Key risk factors are reviewed, including the global westernization of diets (usually involving a high intake of red and processed meats, high-fructose corn syrup and unhealthy cooking methods), stress, antibiotics, synthetic food dyes, monosodium glutamate, titanium dioxide, and physical inactivity and/or sedentary behaviour. The gut microbiota is probably at the crossroads of these risk factors and EOCRC. The time course of the disease and the fact that relevant exposures probably occur in childhood raise important methodological issues that are also discussed.

Indexed as

ExposomeGastrointestinal MicrobiomeSedentary BehaviorAge of OnsetAnti-Bacterial AgentsColorectal NeoplasmsColoring AgentsDietDiet, WesternFlavoring AgentsFood HandlingHigh Fructose Corn SyrupHumansObesityRed MeatRisk FactorsAnti-Bacterial AgentsColoring AgentsFlavoring AgentsHigh Fructose Corn SyrupSodium GlutamateTitaniumtitanium dioxide

Identifiers

PMID32086499
PMCPMC10711686

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.